Independent Director · RIGEL PHARMACEUTICALS INC (RIGL)

Alison L. Hannah, M.D — RIGEL PHARMACEUTICALS Director Compensation (2025)

Fiscal year 2025 director compensation for Alison L. Hannah, M.D at RIGEL PHARMACEUTICALS INC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 3, 2026 (DEF 14A). Open the filing on EDGAR.

Track this executive's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat

A confirmation now and one email when Pro opens, and nothing else. Privacy

What they were paid

RIGEL PHARMACEUTICALS Director Compensation Table · all 2 fiscal years held
In US dollars, as RIGEL PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$75,000$47,375$43,392$0$165,767
FY2024$70,000$22,688$20,566$0$113,254

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RIGEL PHARMACEUTICALS INC DEF 14A filed April 3, 2026, accession 0001034842-26-000023, and prior-year filings. Open the filing on EDGAR.

That is Alison L. Hannah, M.D’s FY2025 figure, as filed. The FY2026 figure the day it is filed: one email, nothing else.

Saved. One email when Alison L. Hannah, M.D’s next annual disclosure lands here, with the figure.

One email when Alison L. Hannah, M.D’s next annual disclosure is on this page, with the figure. Nothing else is sent.

Get the RIGEL PHARMACEUTICALS Board Governance Report

$165,767 Alison L. Hannah, M.D, FY2025 total director compensation

$499

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 3, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Committees

FY2025 · as the proxy prints them

Scientific and Clinical Trial Advisory Committee

The rest of the RIGEL PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Gregg A. LapointeChair of the Board$217,767
Jane Wasman, J.DIndependent Director$172,767
Kamil Ali-JacksonIndependent Director$167,767
Mark W. Frohlich, M.DIndependent Director$288,620
Michael P. MillerIndependent Director—
Raul R. RodriguezDirector—
Walter H. Moos, Ph.DIndependent Director$165,767

The full RIGEL PHARMACEUTICALS compensation record

free company brief

This page is one director within RIGEL PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the RIGEL PHARMACEUTICALS proxy · each links to its own free brief

Order RIGL

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report